231 related articles for article (PubMed ID: 32978625)
1. Tofacitinib Therapy, the Lender of Last Resort.
Rutka M; Pigniczki D; Molnár T
J Crohns Colitis; 2021 Apr; 15(4):694. PubMed ID: 32978625
[No Abstract] [Full Text] [Related]
2. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
Kotwani P; Terdiman J; Lewin S
J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.
Honap S; Pavlidis P; Ray S; Sharma E; Anderson S; Sanderson JD; Mawdsley J; Samaan MA; Irving PM
Inflamm Bowel Dis; 2020 Oct; 26(11):e147-e149. PubMed ID: 32566937
[No Abstract] [Full Text] [Related]
4. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ; Su C; Sands BE; D'Haens GR; Vermeire S; Schreiber S; Danese S; Feagan BG; Reinisch W; Niezychowski W; Friedman G; Lawendy N; Yu D; Woodworth D; Mukherjee A; Zhang H; Healey P; Panés J;
N Engl J Med; 2017 May; 376(18):1723-1736. PubMed ID: 28467869
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tofacitinib treatment in ulcerative colitis.
Panés J; Gisbert JP
Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses.
Pantavou K; Yiallourou AI; Piovani D; Evripidou D; Danese S; Peyrin-Biroulet L; Bonovas S; Nikolopoulos GK
United European Gastroenterol J; 2019 Dec; 7(10):1285-1303. PubMed ID: 31839954
[TBL] [Abstract][Full Text] [Related]
7. [Tofacitinib for the treatment of ulcerative colitis. Report of two cases].
Quera R; Flores L; Núñez P; Ibáñez P
Rev Med Chil; 2020 Jul; 148(7):1039-1043. PubMed ID: 33399691
[No Abstract] [Full Text] [Related]
8. Use of Tofacitinib for Ulcerative Colitis in a Liver Transplant Patient.
Meunier L; Clerc C; Meszaros M
J Crohns Colitis; 2021 Apr; 15(4):695. PubMed ID: 32072164
[No Abstract] [Full Text] [Related]
9. Experience with tofacitinib in patients with refractary ulcerative colitis.
López González J; Hernández Martínez Á; Lázaro Sáez M; Vega Sáenz JL
Gastroenterol Hepatol; 2021 Apr; 44(4):300-301. PubMed ID: 33051048
[No Abstract] [Full Text] [Related]
10. A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.
Sato S; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Furuya M; Gunji N; Fujiwara T; Asano T; Onizawa M; Kobayashi H; Watanabe H; Ohira H; Migita K
Rheumatology (Oxford); 2020 Jul; 59(7):1773-1775. PubMed ID: 31776552
[No Abstract] [Full Text] [Related]
11. Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
Panaccione R; Isaacs JD; Chen LA; Wang W; Marren A; Kwok K; Wang L; Chan G; Su C
Dig Dis Sci; 2021 Aug; 66(8):2732-2743. PubMed ID: 32816215
[TBL] [Abstract][Full Text] [Related]
12. Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report.
Queiroz NSF; Graciolli CB; Sobrado CW
Inflamm Bowel Dis; 2020 Nov; 26(12):e155-e156. PubMed ID: 32676668
[No Abstract] [Full Text] [Related]
13. Nonbiologic Immune Suppression in Ulcerative Colitis.
Heron V; Loftus EV
Gastroenterol Clin North Am; 2020 Dec; 49(4):731-738. PubMed ID: 33121692
[TBL] [Abstract][Full Text] [Related]
14. Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
Danese S; D'Amico F; Bonovas S; Peyrin-Biroulet L
Inflamm Bowel Dis; 2018 Sep; 24(10):2106-2112. PubMed ID: 29697791
[TBL] [Abstract][Full Text] [Related]
15. Is tofacitinib a game-changing drug for ulcerative colitis?
Magro F; Estevinho MM
United European Gastroenterol J; 2020 Aug; 8(7):755-763. PubMed ID: 32552501
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes.
Panés J; Su C; Bushmakin AG; Cappelleri JC; Mamolo C; Healey P
BMC Gastroenterol; 2015 Feb; 15():14. PubMed ID: 25651782
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib in ulcerative colitis - In the era of precision medicine'.
Harindranath S; Singh A
Dig Liver Dis; 2024 May; 56(5):909-910. PubMed ID: 38310053
[No Abstract] [Full Text] [Related]
18. Next generation of small molecules in inflammatory bowel disease.
Olivera P; Danese S; Peyrin-Biroulet L
Gut; 2017 Feb; 66(2):199-209. PubMed ID: 27856614
[No Abstract] [Full Text] [Related]
19. Tofacitinib in ulcerative colitis.
Archer TP; Moran GW; Ghosh S
Immunotherapy; 2016 May; 8(5):495-502. PubMed ID: 27140405
[TBL] [Abstract][Full Text] [Related]
20. Tofacitinib in cardiovascular outcomes: friend or foe?
Xie W; Zhang Z
Rheumatology (Oxford); 2020 Aug; 59(8):1797-1798. PubMed ID: 32163579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
